Telavancin
55 interactions 4 explained in plain English
Also sold as:
Vibativ
Medically reviewed by
Dr. Brian Staiger, PharmD, BCPS
· Updated Jul 4, 2026
· Editorial policy
· Data sources
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Most serious with:
Heparin
Heparin Injection
Sertraline
Levofloxacin Injection
Amisulpride Injection
Arsenic Trioxide
Major
Telavancin Levofloxacin Levaquin Increased risk of QT interval prolongation Details Telavancin Levofloxacin Injection Levaquin Increased risk of QT interval prolongation Details Telavancin Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) Details Telavancin Mefloquine Lariam® An increased risk of QT interval prolongation Details Telavancin Metronidazole Flagyl An increased risk of QT interval prolongation Details Telavancin Metronidazole Injection Flagyl An increased risk of QT interval prolongation Details Telavancin Metronidazole Topical MetroCream® An increased risk of QT interval prolongation Details Telavancin Metronidazole Vaginal MetroGel® Vaginal An increased risk of QT interval prolongation Details Telavancin Moxifloxacin Avelox Increased risk of QT interval prolongation Details Telavancin Moxifloxacin Injection Avelox Increased risk of QT interval prolongation Details Telavancin Moxifloxacin Ophthalmic Moxeza® Increased risk of QT interval prolongation Details Telavancin Octreotide Bynfezia An increased risk of QT interval prolongation Details Telavancin Octreotide Injection Bynfezia An increased risk of QT interval prolongation Details Telavancin Olodaterol Oral Inhalation Striverdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Telavancin Oxaliplatin Injection Eloxatin® Increased risk of QT-interval prolongation DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacistEducational information only, not medical advice. Always confirm interactions with your pharmacist
or prescriber before making any change to your medications.